Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Feedback Loops01:01

Feedback Loops

66.0K
In most cases, excessive hormone production is prevented by negative feedback—a loop that starts with a stimulus inducing the release of a particular substance, like a hormone, to maintain a certain level before triggering a signal that results in a decrease in further release of the hormone.
66.0K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

5.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.6K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

1.2K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.2K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

1.1K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.1K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

14.6K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
14.6K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

5.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-World Associations of KidneyIntelX Risk Stratification With Guideline-Directed Therapy, Kidney Outcomes, and Metabolic Trajectories in Early Diabetic Kidney Disease.

Diabetes, obesity & metabolism·2026
Same author

Smart manufacturing for continuous downstream processing of monoclonal antibodies at the lab-scale.

SLAS technology·2026
Same author

Impact of Early Initiation of Automated Insulin Delivery on Glycemia Two Years from Type 1 Diabetes Diagnosis.

Hormone research in paediatrics·2026
Same author

Raising the Bar: High Time in Range During the First Year of Diagnosis of Type 1 Diabetes in Children and Adolescents Using Automated Insulin Delivery with Intense Support.

Diabetes technology & therapeutics·2026
Same author

Quantifying the Effect of Fat and Protein on the Postprandial Glucose Excursion in Individuals With Type 1 Diabetes Using an Automated Insulin Delivery System.

Journal of diabetes science and technology·2026
Same author

Swimming With the Omnipod 5 Automated Insulin Delivery System: An Observational Investigation of Swimmers With Type 1 Diabetes in the Omnipod 5 Pivotal Trial.

Diabetes, obesity & metabolism·2026

Related Experiment Video

Updated: Feb 25, 2026

Control of Eating Behavior Using a Novel Feedback System
04:48

Control of Eating Behavior Using a Novel Feedback System

Published on: May 8, 2018

11.7K

Closed-Loop Control Without Meal Announcement in Type 1 Diabetes.

Faye M Cameron1, Trang T Ly2, Bruce A Buckingham2

  • 11 Department of Chemical and Biological Engineering, Rensselaer Polytechnic Institute , Troy, New York.

Diabetes Technology & Therapeutics
|August 3, 2017
PubMed
Summary

A new closed-loop insulin system for type 1 diabetes automatically controls glucose without meal announcements. This system shows promise for improving glycemic control and reducing hypoglycemia events.

Keywords:
Artificial pancreasClosed-loop systemsContinuous glucose monitoring.Postprandial blood glucose

More Related Videos

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
07:35

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique

Published on: January 26, 2024

2.3K
Simple Continuous Glucose Monitoring in Freely Moving Mice
03:25

Simple Continuous Glucose Monitoring in Freely Moving Mice

Published on: February 24, 2023

8.2K

Related Experiment Videos

Last Updated: Feb 25, 2026

Control of Eating Behavior Using a Novel Feedback System
04:48

Control of Eating Behavior Using a Novel Feedback System

Published on: May 8, 2018

11.7K
Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
07:35

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique

Published on: January 26, 2024

2.3K
Simple Continuous Glucose Monitoring in Freely Moving Mice
03:25

Simple Continuous Glucose Monitoring in Freely Moving Mice

Published on: February 24, 2023

8.2K

Area of Science:

  • Endocrinology
  • Biomedical Engineering
  • Diabetes Technology

Background:

  • Type 1 diabetes management requires continuous glucose monitoring and insulin delivery.
  • Automated insulin delivery systems aim to improve glycemic control and reduce the burden of self-management.
  • Fully closed-loop systems offer the potential for improved glucose regulation without user intervention for meals or activity.

Purpose of the Study:

  • To assess the initial safety and efficacy of a fully closed-loop insulin-only system.
  • To evaluate a novel multiple model probabilistic controller (MMPPC) for automated glucose control.
  • To determine if the system can manage glucose levels without requiring meal or activity announcements.

Main Methods:

  • Development of a fully closed-loop insulin-only system utilizing a multiple model probabilistic controller (MMPPC).
  • System initialization used patient's basal rates and total daily insulin dose.
  • Testing involved inpatient (30-h, 10 patients) and supervised hotel studies (54-h, 15 patients) with unannounced meals and exercise.

Main Results:

  • The system demonstrated glucose control in both inpatient and hotel study settings.
  • Mean overall CGM values were 142 mg/dL (inpatient) and 152 mg/dL (hotel).
  • Hypoglycemia events decreased from 1.6 to 0.91 events/patient/day in the hotel study.

Conclusions:

  • The MMPPC system achieved mean glucose levels that could benefit individuals with elevated A1c due to missed meal boluses.
  • The fully closed-loop system shows potential for improved diabetes management.
  • Further comparison with meal-announcing algorithms is needed to fully assess hypoglycemia risk.